{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:08:21Z","timestamp":1763510901649,"version":"3.45.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K12533","JP24K12579","JP23K27734 and JP22K19603"],"award-info":[{"award-number":["JP24K12533","JP24K12579","JP23K27734 and JP22K19603"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ASKA Pharmaceutical Co., Ltd."},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science,Japan","doi-asserted-by":"crossref","award":["JP24K12626"],"award-info":[{"award-number":["JP24K12626"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23721-5","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:43:54Z","timestamp":1763135034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of female hormone withdrawal and ulipristal acetate on MED12 mutation positive and negative uterine leiomyomas using a xenograft model"],"prefix":"10.1038","volume":"15","author":[{"given":"Shun","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Tamehisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amon","family":"Shiroshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Kajimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Sugino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"23721_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","volume":"357","author":"EA Stewart","year":"2001","unstructured":"Stewart, E. A. Uterine fibroids. Lancet 357, 293\u2013298 (2001).","journal-title":"Lancet"},{"key":"23721_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/humupd\/6.6.614","volume":"6","author":"N Bajekal","year":"2000","unstructured":"Bajekal, N. & Li, T. C. Fibroids, infertility and pregnancy wastage. Hum. Reprod. Update. 6, 614\u2013620 (2000).","journal-title":"Hum. Reprod. Update"},{"key":"23721_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N M\u00e4kinen","year":"2011","unstructured":"M\u00e4kinen, N. et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334, 252\u2013255 (2011).","journal-title":"Science"},{"key":"23721_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1302736","volume":"369","author":"M Mehine","year":"2013","unstructured":"Mehine, M. et al. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl. J. Med. 369, 43\u201353 (2013).","journal-title":"N Engl. J. Med."},{"key":"23721_CR5","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1172\/JCI81534","volume":"125","author":"P Mittal","year":"2015","unstructured":"Mittal, P. et al. Med12 gain-of-function mutation causes leiomyomas and genomic instability. J. Clin. Invest. 125, 3280\u20133284 (2015).","journal-title":"J. Clin. Invest."},{"key":"23721_CR6","doi-asserted-by":"publisher","first-page":"e33251","DOI":"10.1371\/journal.pone.0033251","volume":"7","author":"MM McGuire","year":"2012","unstructured":"McGuire, M. M. et al. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. PLoS One. 7, e33251. https:\/\/doi.org\/10.1371\/journal.pone.0033251 (2012).","journal-title":"PLoS One"},{"key":"23721_CR7","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","volume":"27","author":"E Bertsch","year":"2014","unstructured":"Bertsch, E. et al. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod. Pathol. 27, 1144\u20131153 (2014).","journal-title":"Mod. Pathol."},{"key":"23721_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/AOG.0000000000005475","volume":"143","author":"T Tamehisa","year":"2024","unstructured":"Tamehisa, T. et al. Establishment of noninvasive prediction models for the diagnosis of uterine leiomyoma subtypes. Obstet. Gynecol. 143, 358\u2013365 (2024).","journal-title":"Obstet. Gynecol."},{"key":"23721_CR9","doi-asserted-by":"publisher","first-page":"30652","DOI":"10.1038\/srep30652","volume":"6","author":"S Sato","year":"2016","unstructured":"Sato, S. et al. Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application. Sci. Rep. 6, 30652. https:\/\/doi.org\/10.1038\/srep30652 (2016).","journal-title":"Sci. Rep."},{"key":"23721_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1262\/jrd.2013-095","volume":"60","author":"S Sato","year":"2014","unstructured":"Sato, S. et al. Potential mechanisms of aberrant DNA hypomethylation on the x chromosome in uterine leiomyomas. J. Reprod. Dev. 60, 47\u201354 (2014).","journal-title":"J. Reprod. Dev."},{"key":"23721_CR11","doi-asserted-by":"publisher","unstructured":"Maekawa, R. et al. Different DNA methylome, transcriptome and histological features in uterine fibroids with and without MED12 mutations. Sci. Rep. 12 https:\/\/doi.org\/10.1038\/s41598-022-12899-7 (2022).","DOI":"10.1038\/s41598-022-12899-7"},{"key":"23721_CR12","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.1158\/0008-5472.CAN-17-1744","volume":"77","author":"X Wu","year":"2017","unstructured":"Wu, X. et al. Subtype-Specific Tumor-Associated fibroblasts contribute to the pathogenesis of uterine leiomyoma. Cancer Res. 77, 6891\u20136901 (2017).","journal-title":"Cancer Res."},{"key":"23721_CR13","doi-asserted-by":"publisher","unstructured":"Nagai, K. et al. MED12 mutations in uterine leiomyomas: prediction of volume reduction by gonadotropin-releasing hormone agonists. Am. J. Obstet. Gynecol.. 228, 207 e1- e9 https:\/\/doi.org\/10.1016\/j.ajog.2022.09.024 (2023).","DOI":"10.1016\/j.ajog.2022.09.024"},{"key":"23721_CR14","doi-asserted-by":"publisher","unstructured":"Rabe, T. et al. Selective progesterone receptor modulators for the medical treatment of uterine fibroids with a focus on ulipristal acetate. Biomed. Res. Int. 1374821 https:\/\/doi.org\/10.1155\/2018\/1374821 (2018).","DOI":"10.1155\/2018\/1374821"},{"key":"23721_CR15","first-page":"2192","volume":"83","author":"Y Shimomura","year":"1998","unstructured":"Shimomura, Y., Matsuo, H., Samoto, T. & Maruo, T. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J. Clin. Endocrinol. Metab. 83, 2192\u20132198 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"23721_CR16","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1210\/jc.2007-0725","volume":"92","author":"P Yin","year":"2007","unstructured":"Yin, P. et al. Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. J. Clin. Endocrinol. Metab. 92, 4459\u20134466 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"23721_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.trsl.2013.11.008","volume":"163","author":"N Luo","year":"2014","unstructured":"Luo, N. et al. Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation. Transl Res. 163, 232\u2013241 (2014).","journal-title":"Transl Res."},{"key":"23721_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.fertnstert.2024.02.046","volume":"122","author":"G Milewska","year":"2014","unstructured":"Milewska, G. et al. Functional evidence for two distinct mechanisms of action of progesterone and selective progesterone receptor modulator on uterine leiomyomas. Fertil. Steril. 122, 341\u2013351 (2014).","journal-title":"Fertil. Steril."},{"key":"23721_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/humupd\/dmh019","volume":"10","author":"T Maruo","year":"2004","unstructured":"Maruo, T., Ohara, N., Wang, J. & Matsuo, H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum. Reprod. Update. 10, 207\u2013220 (2004).","journal-title":"Hum. Reprod. Update"},{"key":"23721_CR20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/humrep\/deh146","volume":"19","author":"T Yamada","year":"2004","unstructured":"Yamada, T. et al. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells. Hum. Reprod. 19, 815\u2013821 (2004).","journal-title":"Hum. Reprod."},{"key":"23721_CR21","doi-asserted-by":"publisher","first-page":"e0158578","DOI":"10.1371\/journal.pone.0158578","volume":"11","author":"C Bonazza","year":"2016","unstructured":"Bonazza, C. et al. Primary human uterine leiomyoma cell culture quality control: some properties of myometrial cells cultured under serum deprivation conditions in the presence of ovarian steroids. PLoS One. 11, e0158578. https:\/\/doi.org\/10.1371\/journal.pone.0158578 (2016).","journal-title":"PLoS One"},{"key":"23721_CR22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1210\/jc.2004-1569","volume":"90","author":"Q Xu","year":"2005","unstructured":"Xu, Q. et al. Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and Poly (adenosine 5\u2019-diphosphate-ribose) Polymerase expression in cultured human uterine leiomyoma cells. J. Clin. Endocrinol. Metab. 90, 953\u2013961 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"23721_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/molehr\/gan004","volume":"14","author":"Q Xu","year":"2008","unstructured":"Xu, Q. et al. Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells. Mol. Hum. Reprod. 14, 181\u2013191 (2008).","journal-title":"Mol. Hum. Reprod."},{"key":"23721_CR24","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1093\/humrep\/del159","volume":"21","author":"Q Xu","year":"2006","unstructured":"Xu, Q. et al. Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells. Hum. Reprod. 21, 2408\u20132416 (2006).","journal-title":"Hum. Reprod."},{"key":"23721_CR25","doi-asserted-by":"publisher","first-page":"34762","DOI":"10.18632\/oncotarget.16711","volume":"8","author":"J Bloch","year":"2017","unstructured":"Bloch, J., Holzmann, C., Koczan, D., Helmke, B. M. & Bullerdiek, J. Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth. Oncotarget 8, 34762\u201334772 (2017).","journal-title":"Oncotarget"},{"key":"23721_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/gcc.22142","volume":"53","author":"MD Nadine","year":"2014","unstructured":"Nadine, M. D. et al. Cell cultures in uterine leiomyomas: rapid disappearance of cells carrying MED12 mutations. Genes Chromosomes Cancer. 53, 317\u2013323 (2014).","journal-title":"Genes Chromosomes Cancer"},{"key":"23721_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/molehr\/2.11.823","volume":"2","author":"MF Severino","year":"1996","unstructured":"Severino, M. F. et al. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures. Mol. Hum. Reprod. 2, 823\u2013828 (1996).","journal-title":"Mol. Hum. Reprod."},{"key":"23721_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/molehr\/gal018","volume":"12","author":"M Zaitseva","year":"2006","unstructured":"Zaitseva, M., Vollenhoven, B. J. & Rogers, P. A. In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells. Mol. Hum. Reprod. 12, 187\u2013207 (2006).","journal-title":"Mol. Hum. Reprod."},{"key":"23721_CR29","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1210\/en.2009-1225","volume":"151","author":"H Ishikawa","year":"2010","unstructured":"Ishikawa, H. et al. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology 151, 2433\u20132442 (2010).","journal-title":"Endocrinology"},{"key":"23721_CR30","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1530\/ERC-18-0184","volume":"25","author":"VA Serna","year":"2018","unstructured":"Serna, V. A. et al. Cellular kinetics of MED12-mutant uterine leiomyoma growth and regression in vivo. Endocr. Relat. Cancer. 25, 747\u2013759 (2018).","journal-title":"Endocr. Relat. Cancer"},{"key":"23721_CR31","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.14440\/jbm.2018.243","volume":"5","author":"VA Serna","year":"2018","unstructured":"Serna, V. A. & Kurita, T. Patient-derived xenograft model for uterine leiomyoma by sub-renal capsule grafting. J. Biol. Methods. 5, e91. https:\/\/doi.org\/10.14440\/jbm.2018.243 (2018).","journal-title":"J. Biol. Methods"},{"key":"23721_CR32","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"23721_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"23721_CR34","doi-asserted-by":"crossref","unstructured":"Sugino, N. et al. Uterine fibroids and adenomyosis. (ed. Sugino, N.) 1-173 (Springer, 2018).","DOI":"10.1007\/978-981-10-7167-6"},{"key":"23721_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa1103180","volume":"366","author":"J Donnez","year":"2012","unstructured":"Donnez, J. et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl. J. Med. 366, 421\u2013432 (2012).","journal-title":"N Engl. J. Med."},{"key":"23721_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/rmb2.12304","volume":"19","author":"M Irahara","year":"2019","unstructured":"Irahara, M., Maejima, Y., Shinbo, N., Yamauchi, Y. & Mizunuma, H. Ulipristal acetate for Japanese women with symptomatic uterine fibroids: A double-blind, randomized, phase II dose-finding study. Reprod. Med. Biol. 19, 65\u201374 (2019).","journal-title":"Reprod. Med. Biol."},{"key":"23721_CR37","doi-asserted-by":"publisher","first-page":"e12627","DOI":"10.1002\/rmb2.12627","volume":"24","author":"T Sakai","year":"2025","unstructured":"Sakai, T. et al. Establishment of a 3D spheroid culture system to evaluate the responsiveness of uterine leiomyoma cells to female hormones. Reprod. Med. Biol. 24, e12627. https:\/\/doi.org\/10.1002\/rmb2.12627 (2025).","journal-title":"Reprod. Med. Biol."},{"key":"23721_CR38","doi-asserted-by":"crossref","unstructured":"Ahmed, A. & Tait, S. W. G. Targeting Immunogenic cell death in cancer. Mol. Oncol. 2994\u20133006 (2020).","DOI":"10.1002\/1878-0261.12851"},{"key":"23721_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier, P., Legrand, A. J., Adam, D. & Silke, J. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat. Rev. Cancer. 24, 299\u2013315 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"23721_CR40","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s10815-019-01582-y","volume":"36","author":"S Sato","year":"2019","unstructured":"Sato, S. et al. SATB2 and NGR1: potential upstream regulatory factors in uterine leiomyomas. J. Assist. Reprod. Genet. 36, 2385\u20132397 (2019).","journal-title":"J. Assist. Reprod. Genet."},{"key":"23721_CR41","doi-asserted-by":"publisher","first-page":"e66632","DOI":"10.1371\/journal.pone.0066632","volume":"8","author":"R Maekawa","year":"2013","unstructured":"Maekawa, R. et al. Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas. PLoS One. 8, e66632. https:\/\/doi.org\/10.1371\/journal.pone.0066632 (2013).","journal-title":"PLoS One"},{"key":"23721_CR42","doi-asserted-by":"publisher","unstructured":"Nair, H. B. et al. EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model. Sci. Rep. 9 https:\/\/doi.org\/10.1038\/s41598-019-53467-w (2019).","DOI":"10.1038\/s41598-019-53467-w"},{"key":"23721_CR43","doi-asserted-by":"publisher","unstructured":"Liang, B. et al. Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice. Reprod. Biol. Endocrinol. 16 https:\/\/doi.org\/10.1186\/s12958-018-0347-9 (2018).","DOI":"10.1186\/s12958-018-0347-9"},{"key":"23721_CR44","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1210\/clinem\/dgz139","volume":"105","author":"B Small","year":"2010","unstructured":"Small, B. et al. The selective progesterone receptor modulator ulipristal acetate inhibits the activity of the glucocorticoid receptor. J. Clin. Endocrinol. Metab. 105, 716\u2013734 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"23721_CR45","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.fertnstert.2014.01.054","volume":"101","author":"G Wang","year":"2014","unstructured":"Wang, G. et al. Nonobese diabetic\/severe combined immunodeficient murine xenograft model for human uterine leiomyoma. Fertil. Steril. 101, 1485\u20131492 (2014).","journal-title":"Fertil. Steril."},{"key":"23721_CR46","doi-asserted-by":"publisher","first-page":"bqab128","DOI":"10.1210\/endocr\/bqab128","volume":"162","author":"Y Shirafuta","year":"2021","unstructured":"Shirafuta, Y. et al. Integrated analysis of transcriptome and histone modifications in granulosa cells during ovulation in female mice. Endocrinology 162, bqab128. https:\/\/doi.org\/10.1210\/endocr\/bqab128 (2021).","journal-title":"Endocrinology"},{"key":"23721_CR47","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"23721_CR48","doi-asserted-by":"publisher","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10 https:\/\/doi.org\/10.1038\/s41467-019-09234-6 (2019).","DOI":"10.1038\/s41467-019-09234-6"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23721-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23721-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23721-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:06:23Z","timestamp":1763510783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23721-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23721"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23721-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sato S, Sakai T, Tamehisa T, and Sugino N received research funding from ASKA Pharmaceutical Co., Ltd. The other authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40028"}}